InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（6 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
6
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Plavsic Mark, 首席技术官. Officer active across 2 companies, notably Fate Therapeutics INC. Aggregated, 11 filings have been logged. Split: 0 buy · 6 sells. Total volume traded: €323k. History available since 14 June 2021. The latest transaction was disclosed on 2 March 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Plavsic Mark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
62,339 股0Common StockSEC:0001193125-26-088158:0
15,890 股@ US$5.0531.3% 占其流量Common StockSEC:0001193125-26-055497:0
12,169 股@ US$6.3544.4% 占其流量Common StockSEC:0001193125-25-241622:0
2,151 股@ US$7.7519.2% 占其流量Common StockSEC:0000950170-25-022655:0
90,475 股0Common StockSEC:0000950170-25-013829:0
7,383 股@ US$9.8580.8% 占其流量Common StockSEC:0000950170-24-115150:0
3,418 股@ US$5.2415.8% 占其流量Common StockSEC:0001209191-23-002976:0
3,719 股@ US$24.6184.2% 占其流量Common StockSEC:0001209191-22-041053:0
33,302 股0Common StockSEC:0000899243-22-003447:0
59,540 股0Common StockSEC:0001209191-21-066162:0
38,000 股0Common StockSEC:0001209191-21-042373:0
11 条申报中的 11 条
About Plavsic Mark
Plavsic Mark is Directeur Technique at Aura Biosciences, Inc. and Fate Therapeutics INC. Across 11 filings recorded, the 11 sampled filings, from 2021-06-22 to 2026-03-03, show sales of EUR 322525 and no purchases, with the modal transaction nature listed as Cession.
